Crescent Biopharma (CBIO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Crescent Biopharma (CBIO) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Crescent Biopharma

· CBIO

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

536.22 M

-2.19%

General

Market Cap: $548.24M
Enterprise Value: $362.49M
Shares Outstanding: 35,670,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 100.00%
Operating Margin: -1417.74%
Net Profit Margin: -1371.51%
FCF Margin: -1292.75%
ROA: -89.18%
ROE: -97.77%
ROIC: -102.29%
Current Ratio: 9.66
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 44.82
P/FCF: —
P/B: 3.26
EV/EBITDA: -2.23

Growth

Rev 1Y: —
Rev 1Y Fwd Est: -82.79%
Rev 3Y (CAGR): 424.86%
Rev 5Y (CAGR): 1.31%
Rev 10Y (CAGR): -5.97%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $11.88M
Gross Margin: 100.00%
Operating Expenses: $180.35M
Operating Income: -$168.47M
Net Profit: -$162.98M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $171.59M
Working Capital: $160.47M
Total Assets: $182.76M
Net Debt: -$170.16M
Total Liabilities: $19.5M
Total Equity: $163.26M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$72.68M
Cash Flow from Investing: -$79.17M
Cash Flow from Financing: $170.8M
Free Cash Flow: -$153.62M
Capital Expenditures: $80.94M